The development of new bicyclic pyrazole-based cytokine synthesis inhibitors.
Bioorg Med Chem Lett
; 14(19): 4945-8, 2004 Oct 04.
Article
em En
| MEDLINE
| ID: mdl-15341957
ABSTRACT
4-Aryl-5-pyrimidyl-based cytokine synthesis inhibitors of TNF-alpha production, which contain a novel bicyclic pyrazole heterocyclic core, are described. Many of these inhibitors showed low nanomolar activity against LPS-induced TNF-alpha production in a THP-1 cell-based assay and against human p38 alpha MAP kinase in an isolated enzyme assay. The X-ray crystal structure of a bicyclic pyrazole inhibitor co-crystallized with mutated p38 (mp38) is presented.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Pirazóis
/
Fator de Necrose Tumoral alfa
/
Proteínas Quinases p38 Ativadas por Mitógeno
/
Inibidores Enzimáticos
Limite:
Humans
Idioma:
En
Revista:
Bioorg Med Chem Lett
Ano de publicação:
2004
Tipo de documento:
Article